drugset / Trial / NCT00414752

Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking

NCT00414752 ↗

Phase 1 Completed 36 enrolled Novartis
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to assess the safety and efficacy of AFQ056 and nicotine compared to placebo on craving and withdrawal symptoms during voluntary smoking stoppage in healthy smokers. This study will also assess how the body interacts with AFQ056.

Timeline

Start
2006-09
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject AFQ065 Unknown — —

Indications

No indication recorded.